Idec Zevalin Phase IV Planned In Murine-Based Cancer Therapy Patients
Executive Summary
Idec plans to conduct a Phase IV Zevalin trial to study use of the radioimmunotherapy in patients previously exposed to murine-based anti-cancer therapies, if the product is approved by FDA.